MedTrace Logo

Use of Glubran 2 ® in Axillary Lymphadenectomy Without Drain

NCT05280353 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2024-09-04

No results posted yet for this study

Summary

Axillary lymphadenectomy in breast cancer continues to be a common practice in certain patients. The use of sealants and drains continues to be a source of disagreement among the scientific community. That is why the study was designed to show whether the sealant reduces seroma after axillary lymphadenectomy without drainage.

Conditions

  • Seroma Following Procedure

Interventions

OTHER

Glubran 2

Application of Glubran 2 sealant (liquid) in axillary hollow

Sponsors & Collaborators

  • Consorci Sanitari del Maresme

    collaborator OTHER

  • Omphis Foundation

    lead OTHER

Principal Investigators

  • Sandra Lopez Gordo, Doctor · Health Consortium Maresme

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2025-06-01
Completion
2026-06-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05280353 on ClinicalTrials.gov